Medical editor: Assoc. Prof. Cengiz Dibekoğlu, MDLast reviewed:
Peritoneal Metastasis, CRS & HIPEC
Two components — not a miracle package for everyone
First question: is complete cytoreduction possible? HIPEC is not automatic.
Cytoreductive surgery (CRS) and HIPEC are related but separate. CRS aims to remove visible peritoneal disease; HIPEC adds heated intraperitoneal chemotherapy in selected protocols afterward. HIPEC is not standard for all peritoneal disease and is not an automatic add-on to every CRS. In colorectal peritoneal metastases, PRODIGE-7 showed no overall-survival benefit for oxaliplatin HIPEC — this must be discussed honestly. PCI score, primary tumor type, fitness, and likelihood of complete cytoreduction decide candidacy. If you are not a candidate, saying so clearly is better than the wrong large operation.
- Hero figure: thick liver lobe on the left of the figure, with mixed flat and raised deposits and an omental cake.
- Related figures explain cytoreduction, intraperitoneal chemotherapy, and patient selection themes.
Educational figures
Tap a figure to enlarge. These English illustrations mirror the Turkish hub gallery for this condition.
PCI & CC score Candidacy Process Limits
What to know
What CRS means
Surgical removal of visible peritoneal disease aiming for completeness (CC-0/CC-1). Incomplete cytoreduction rarely justifies maximal morbidity.
- Key note inside
What HIPEC means
HIPEC is not standard for everyone.Heated intraperitoneal chemotherapy after CRS in selected protocols — not mandatory for every CRS.
- Key note inside
Evidence boundaries
In colorectal peritoneal metastases, oxaliplatin HIPEC did not improve overall survival in PRODIGE-7. Other histologies and protocols have different evidence weight.
- Key note inside
Gastric + extensive peritoneum
Gastric cancer with extensive peritoneal disease rarely fits a curative HIPEC narrative. Goals must stay realistic.
Who is reviewed
Patients with limited PCI, favorable biology, and fitness for major surgery are discussed at the tumor board with complete imaging and prior operative records.
What happens next
CRS vs HIPEC, PCI and CC scoring in plain language
- 1
What CRS and HIPEC Are
CRS vs HIPEC, PCI and CC scoring in plain language
Read this chapter - 2
CRS / HIPEC Eligibility
Which diseases, how scores guide the talk
Read this chapter - 3
CRS / HIPEC Process
Process — explained for shared decision-making
Read this chapter - 4
Limits of CRS / HIPEC
Limits — explained for shared decision-making
Read this chapter
Scientific evidence atlas
Plain-language summaries of the key clinical trials behind current treatment decisions.
Evidence
Scientific sources
Show sources · 4Guidelines and key evidence for peritoneal metastases / HIPEC decisions. HIPEC is not automatic with every CRS.
Evidence
Scientific sources
- ESMO metastatic colorectal cancer guideline (peritoneal disease context)ESMO · 2023 · DOI: 10.1016/j.annonc.2022.10.003Open source
- PRODIGE 7 — Cytoreductive surgery with or without oxaliplatin HIPEC in colorectal peritoneal metastases (RCT)Lancet Oncology (clinical study; not a guideline) · 2021 · DOI: 10.1016/S1470-2045(20)30599-4Open source
- PSOGI — Peritoneal Surface Oncology Group International (education / consensus)PSOGI · Resource portalOpen source
- NCCN Clinical Practice Guidelines in Oncology: Colon CancerNational Comprehensive Cancer Network (NCCN) · Current versionOpen source
Source list last checked: 21 August 2026. (Page content review date may appear separately above.)
Appointment / info
Complete imaging and prior operative/pathology records are required for a serious CRS/HIPEC review.
This page is for education. It is not medical advice and does not replace a visit with your physician.
Medical editor: Assoc. Prof. Cengiz Dibekoğlu, MD · English patient-education hub.